Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects

References

• Despres JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien PJ, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes. 1989; 38: 304–9
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 1997; 46: 1579–85
   PubMed Web of Science ®Google Scholar
• Rönnemaa T, Koskenvuo M, Marniemi J, Koivunen T, Sajantila A, Rissanen A, et al. Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat. J Clin Endocrinol Metab. 1997; 82: 383–7
   PubMed Web of Science ®Google Scholar
• Björntorp P. ‘Portal’ adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990; 10: 493–6
   PubMedGoogle Scholar
• Ruan H, Lodish HF. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines. Curr Opin Lipidol. 2004; 15: 297–302
   PubMed Web of Science ®Google Scholar
• Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab. 2002; 282: E657–63
   PubMed Web of Science ®Google Scholar
• Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab. 2002; 87: 5044–51
   PubMed Web of Science ®Google Scholar
• Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995; 96: 88–98
   PubMed Web of Science ®Google Scholar
• Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome?. Human model. Obesity (Silver Spring). 2006; 14(Suppl 1)20S–4S
   Web of Science ®Google Scholar
• Das UN. Is obesity an inflammatory condition?. Nutrition. 2001; 17: 953–66
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425–32
   PubMed Web of Science ®Google Scholar
• Himms-Hagen J. Physiological roles of the leptin endocrine system: differences between mice and humans. Crit Rev Clin Lab Sci. 1999; 36: 575–655
   PubMed Web of Science ®Google Scholar
• Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998; 394: 897–901
   PubMed Web of Science ®Google Scholar
• Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002; 110: 1093–103
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997; 82: 4196–200
   PubMed Web of Science ®Google Scholar
• Virtanen KA, Peltoniemi P, Marjamäki P, Asola M, Strindberg L, Parkkola R, et al. Human adipose tissue glucose uptake determined using [18F]-fluoro-deoxy-glucose ([18F]FDG) and PET in combination with microdialysis. Diabetologia. 2001; 44: 2171–9
   Google Scholar
• Virtanen KA, Lönnroth P, Parkkola R, Peltoniemi P, Asola M, Viljanen T, et al. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab. 2002; 87: 3902–10
   PubMed Web of Science ®Google Scholar
• Viljanen AP, Virtanen KA, Järvisalo MJ, Hällsten K, Parkkola R, Rönnemaa T, et al. Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin. J Clin Endocrinol Metab. 2005; 90: 6523–8
   PubMed Web of Science ®Google Scholar
• Sipilä H, Clark JC, Peltola O, Teräs M. An automatic (O-15)H2O production system for heart and brain studies. J Labelled Comp Radiopharm. 2001; 44: S1066–S1068
   Google Scholar
• Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986; 27: 235–8
   PubMed Web of Science ®Google Scholar
• Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977; 28: 897–916
   PubMed Web of Science ®Google Scholar
• Peltoniemi P, Lönnroth P, Laine H, Oikonen V, Tolvanen T, Grönroos T, et al. Lumped constant for [18F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab. 2000; 279: E1122–30
   Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979; 237: E214–23
   PubMed Web of Science ®Google Scholar
• Abate N, Garg A, Coleman R, Grundy SM, Peshock RM. Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr. 1997; 65: 403–8
   PubMed Web of Science ®Google Scholar
• Lehtimäki T, Ojala P, Rontu R, Goebeler S, Karhunen PJ, Jylhä M, et al. Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians. J Am Geriatr Soc. 2005; 53: 1552–8
   Google Scholar
• Enevoldsen LH, Stallknecht B, Fluckey JD, Galbo H. Effect of exercise training on in vivo lipolysis in intra-abdominal adipose tissue in rats. Am J Physiol Endocrinol Metab. 2000; 279: E585–92
   Google Scholar
• Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord. 2003; 27: 875–88
   PubMed Web of Science ®Google Scholar
• West DB, Prinz WA, Greenwood MR. Regional changes in adipose tissue blood flow and metabolism in rats after a meal. Am J Physiol. 1989; 257: R711–6
   Google Scholar
• Frayn KN, Fielding BA, Summers LK. Investigation of human adipose tissue metabolism in vivo. J Endocrinol. 1997; 155: 187–9
   Google Scholar
• Mårin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism. 1992; 41: 1242–8
   PubMed Web of Science ®Google Scholar
• Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes. 1997; 46: 342–7
   PubMed Web of Science ®Google Scholar
• Orel M, Lichnovska R, Gwozdziewiczova S, Zlamalova N, Klementa I, Merkunova A, et al. Gender differences in tumor necrosis factor alpha and leptin secretion from subcutaneous and visceral fat tissue. Physiol Res. 2004; 53: 501–5
   PubMed Web of Science ®Google Scholar
• Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, et al. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes. 1998; 47: 98–103
   Google Scholar
• Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444: 881–7
   PubMed Web of Science ®Google Scholar
• Virtanen KA, Iozzo P, Hällsten K, Huupponen R, Parkkola R, Janatuinen T, et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron–emitting tomography study. Diabetes. 2005; 54: 2720–6
   Google Scholar
• Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate–pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978; 57: 549–56
   PubMed Web of Science ®Google Scholar
• Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive–leptin concentrations in normal–weight and obese humans. N Engl J Med. 1996; 334: 292–5
   PubMed Web of Science ®Google Scholar
• Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 2001; 226: 963–77
   PubMed Web of Science ®Google Scholar
• Porte D, Jr, Baskin DG, Schwartz MW. Leptin and insulin action in the central nervous system. Nutr Rev. 2002; 60: S20–9
   PubMed Web of Science ®Google Scholar
• Niswender KD, Schwartz MW. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol. 2003; 24: 1–10
   PubMed Web of Science ®Google Scholar
• Fruhbeck G, Aguado M, Martinez JA. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun. 1997; 240: 590–4
   PubMed Web of Science ®Google Scholar
• Keim NL, Stern JS, Havel PJ. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr. 1998; 68: 794–801
   PubMed Web of Science ®Google Scholar
• Westerterp-Plantenga MS, Saris WH, Hukshorn CJ, Campfield LA. Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr. 2001; 74: 426–34
   PubMedGoogle Scholar
• Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998; 392: 398–401
   PubMed Web of Science ®Google Scholar
• Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998; 31: 409–14
   PubMed Web of Science ®Google Scholar
• Knudson JD, Dincer UD, Zhang C, Swafford AN, Jr, Koshida R, Picchi A, et al. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2005; 289: H48–56
   PubMedGoogle Scholar
• Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, et al. Biological action of leptin as an angiogenic factor. Science. 1998; 281: 1683–6
   PubMed Web of Science ®Google Scholar
• Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes. 1999; 48: 903–8
   PubMed Web of Science ®Google Scholar
• Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998; 83: 847–50
   PubMed Web of Science ®Google Scholar
• Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003; 289: 1799–804
   PubMed Web of Science ®Google Scholar
• Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res. 2001; 9: 414–7
   PubMedGoogle Scholar
• Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997; 82: 1313–6
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005; 115: 911–9
   PubMed Web of Science ®Google Scholar
• Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes. 2005; 54: 2305–13
   PubMed Web of Science ®Google Scholar
• Garaulet M, Viguerie N, Porubsky S, Klimcakova E, Clement K, Langin D, et al. Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance. J Clin Endocrinol Metab. 2004; 89: 756–60
   PubMed Web of Science ®Google Scholar
• Anderlova K, Kremen J, Dolezalova R, Housova J, Haluzikova D, Kunesova M, et al. The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol Res. 2006; 55: 277–83
   PubMed Web of Science ®Google Scholar
• Kim MJ, Maachi M, Debard C, Loizon E, Clement K, Bruckert E, et al. Increased adiponectin receptor-1 expression in adipose tissue of impaired glucose-tolerant obese subjects during weight loss. Eur J Endocrinol. 2006; 155: 161–5
   PubMed Web of Science ®Google Scholar
• Coppola A, Marfella R, Coppola L, Tagliamonte E, Fontana D, Liguori E, , et al Effect of weight loss on coronary circulation and adiponectin levels in obese women. Int J Cardiol. 2008 Mar 28 (Epub ahead of print).
   Google Scholar
• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257: 79–83
   PubMed Web of Science ®Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86: 1930–5
   PubMed Web of Science ®Google Scholar
• Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002; 87: 5662–7
   PubMed Web of Science ®Google Scholar
• Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001; 7: 947–53
   PubMed Web of Science ®Google Scholar
• Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001; 108: 1875–81
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001; 7: 941–6
   PubMed Web of Science ®Google Scholar